Ignite Creation Date:
2025-12-24 @ 5:49 PM
Ignite Modification Date:
2025-12-29 @ 11:44 PM
Study NCT ID:
NCT07238868
Status:
RECRUITING
Last Update Posted:
2025-11-20
First Post:
2025-11-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
An Open-label Study to Evaluate Safety, Tolerability, and Efficacy of CB03-154 in Subjects Diagnosed With Epilepsy
Sponsor:
Shanghai Zhimeng Biopharma, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-08-14
Start Date Type:
ACTUAL
Primary Completion Date:
2029-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-06
Completion Date Type:
ESTIMATED
First Submit Date:
2025-11-16
First Submit QC Date:
None
Study First Post Date:
2025-11-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-16
Last Update Post Date:
2025-11-20
Last Update Post Date Type:
ESTIMATED